Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100
Closed -$24.7K 5664
2025
Q3
$24.7K Buy
+100
New +$23.9K ﹤0.01% 4909
2019
Q2
Sell
-23,300
Closed -$2.98M 7257
2019
Q1
$2.98M Buy
+23,300
New +$2.74M ﹤0.01% 2146
2018
Q3
Sell
-15,100
Closed -$1.59M 7374
2018
Q2
$1.59M Buy
+15,100
New +$1.52M ﹤0.01% 2788

Other funds holding STE

Barclays's STE Position: Q2 2026 in Review

Barclays reduced its Steris (STE) stake by 14% in Q2 2026, selling an estimated $4.93M and leaving 141,582 shares worth $29.8M. The position accounts for 0.01% of the portfolio, ranked #934.

Barclays first reported a position in STE in Q2 2013 and has held it in 52 quarters since. The position peaked at $46.3M in Q3 2025. 837 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Barclays held 141,582 shares of Steris worth $29.8M as of Q2 2026.
  • Barclays sold 22,977 Steris shares in Q2 2026, an estimated $4.93M.
  • Steris made up 0.01% of Barclays's portfolio in Q2 2026, its #934 holding.
  • Barclays first reported a position in Steris in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Steris position peaked at $46.3M in Q3 2025.
  • 837 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.